tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Pacific Biosciences of California Inc

PACB
Add to Watchlist
1.350USD
+0.050+3.85%
Close 09-14 16:00（ET）
418.04MMarket Cap
LossP/E TTM

Pacific Biosciences of California Inc

1.350
+0.050+3.85%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

PACB Financials

See Pacific Biosciences of California Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
418.04M
Dividend TTM
0.00
P/E TTM
-3.25
EPS TTM
-0.41
Revenue
160.00M
Net Profit
-309.85M
ROE
-273.55%
ROA
-15.65%

Pacific Biosciences of California Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-0.14/-0.13
Revenue / Forecast
39.01M/40.07M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-3.10%-0.14
98.11%-0.03
-1695.58%-0.13
43.23%-0.13
78.05%-0.14
-394.92%-1.44
102.73%0.01
15.15%-0.22
-127.86%-0.64
20.25%-0.29
17.72%-0.31
---0.26
---0.28
---0.36
---0.37
---1.03
----
----
----
----
Revenue
-1.91%39.01M
0.07%37.18M
13.82%44.65M
-3.82%38.44M
10.42%39.77M
-4.27%37.15M
-32.79%39.22M
-28.23%39.97M
-24.30%36.01M
-0.23%38.81M
113.35%58.36M
72.36%55.69M
34.13%47.57M
17.26%38.90M
-24.06%27.35M
-7.38%32.31M
15.87%35.47M
14.40%33.17M
32.74%36.02M
82.83%34.89M
Net Profit
-6.70%-44.74M
98.06%-8.28M
-1802.70%-40.37M
37.42%-38.00M
75.81%-41.93M
-445.01%-426.07M
102.89%2.37M
9.19%-60.73M
-148.19%-173.32M
11.18%-78.18M
2.80%-82.02M
13.12%-66.87M
2.19%-69.83M
-8.00%-88.02M
-21.72%-84.38M
-565.31%-76.97M
-74.13%-71.39M
6.79%-81.50M
-192.52%-69.33M
169.77%16.54M
Net Margin
-8.78%-114.70%
98.06%-22.26%
-1595.95%-90.43%
34.94%-98.85%
78.09%-105.44%
-469.31%-1146.81%
104.30%6.04%
-26.54%-151.94%
-227.86%-481.27%
10.97%-201.44%
54.44%-140.55%
---120.07%
---146.79%
---226.26%
---308.50%
---227.70%
----
----
----
----
Gross Margin
-13.26%30.26%
103.34%32.30%
154.79%35.26%
219.73%50.84%
362.99%34.89%
-6598.82%-967.20%
6.40%13.84%
-48.40%15.90%
-76.94%7.54%
-40.69%14.88%
-59.77%13.01%
--30.81%
--32.68%
--25.09%
--32.34%
--43.48%
----
----
----
----
Debt to assets ratio
9.43%85.70%
9.67%82.33%
60.23%82.31%
30.42%80.33%
32.40%78.31%
40.39%75.07%
0.47%51.37%
30.95%61.59%
22.35%59.15%
12.83%53.47%
0.55%51.13%
--47.04%
--48.34%
--47.39%
--50.85%
--49.31%
----
----
----
----
Income Statement
Revenue
-1.91%39.01M
0.07%37.18M
13.82%44.65M
-3.82%38.44M
10.42%39.77M
-4.27%37.15M
-32.79%39.22M
-28.23%39.97M
-24.30%36.01M
-0.23%38.81M
113.35%58.36M
72.36%55.69M
34.13%47.57M
17.26%38.90M
-24.06%27.35M
-7.38%32.31M
15.87%35.47M
14.40%33.17M
32.74%36.02M
82.83%34.89M
Operating profit
-2.01%-44.61M
90.84%-38.75M
15.82%-53.19M
67.68%-18.10M
72.26%-18.93M
-419.41%-422.97M
23.84%-63.18M
24.09%-56.01M
4.15%-68.25M
-3.08%-81.43M
-5.29%-82.95M
-4.90%-73.78M
3.01%-71.20M
-0.52%-79.00M
-24.79%-78.78M
-60.78%-70.34M
-95.37%-73.41M
-133.12%-78.59M
-163.29%-63.13M
-80.97%-43.75M
Net Profit
-6.70%-44.74M
98.06%-8.28M
-1802.70%-40.37M
37.42%-38.00M
75.81%-41.93M
-445.01%-426.07M
102.89%2.37M
9.19%-60.73M
-148.19%-173.32M
11.18%-78.18M
2.80%-82.02M
13.12%-66.87M
2.19%-69.83M
-8.00%-88.02M
-21.72%-84.38M
-565.31%-76.97M
-74.13%-71.39M
6.79%-81.50M
-192.52%-69.33M
169.77%16.54M
Balance Sheet
Current assets
-18.08%338.64M
-16.95%369.52M
-24.34%375.05M
-32.52%394.24M
-34.19%413.40M
-34.28%444.92M
-33.20%495.68M
-33.78%584.23M
-32.86%628.14M
-30.99%677.02M
-12.91%742.05M
-3.46%882.30M
-3.58%935.55M
-4.67%981.11M
-22.62%852.07M
-19.11%913.90M
-18.40%970.29M
-13.94%1.03B
209.67%1.10B
371.72%1.13B
Total current liabilities
15.15%68.81M
-1.87%65.36M
9.85%72.83M
5.35%63.21M
-23.77%59.75M
-8.70%66.60M
-30.23%66.30M
-67.39%60.00M
-71.12%78.39M
-72.54%72.95M
-63.91%95.03M
125.31%183.96M
221.59%271.41M
335.46%265.67M
267.23%263.33M
46.83%81.65M
85.76%84.40M
80.84%61.01M
86.25%71.71M
-57.31%55.61M
Total assets
-8.92%751.85M
-9.11%782.37M
-37.79%784.08M
-44.61%803.16M
-45.31%825.47M
-48.45%860.79M
-27.81%1.26B
-23.62%1.45B
-18.30%1.51B
-11.94%1.67B
-1.19%1.75B
4.37%1.90B
-1.52%1.85B
-2.08%1.90B
-11.95%1.77B
-10.58%1.82B
50.60%1.88B
54.58%1.94B
384.80%2.01B
577.33%2.03B
Total liabilities
2.76%785.06M
1.41%780.00M
3.30%778.73M
-23.06%767.07M
-24.86%763.98M
-24.66%769.15M
-27.84%753.85M
-12.13%996.93M
-15.66%1.02B
-15.23%1.02B
-13.24%1.04B
-4.84%1.13B
0.95%1.21B
0.18%1.20B
-0.97%1.20B
-0.08%1.19B
20.93%1.19B
23.63%1.20B
1449.24%1.22B
598.59%1.19B
Total equity
-154.01%-33.21M
-97.42%2.37M
-98.94%5.35M
-92.04%36.09M
-87.52%61.49M
-85.88%91.64M
-27.76%506.59M
-40.67%453.12M
-23.26%492.70M
-6.23%649.02M
24.59%701.30M
21.89%763.74M
-5.85%642.00M
-5.78%692.12M
-28.84%562.90M
-25.48%626.59M
164.05%681.89M
161.83%734.58M
135.77%790.99M
549.29%840.81M
Cash Flow Statement
Net operating income
-21.13%-35.58M
-1.44%-44.69M
37.78%-19.07M
58.85%-18.71M
45.86%-29.38M
41.79%-44.06M
46.75%-30.65M
30.25%-45.46M
-30.00%-54.26M
20.07%-75.68M
4.96%-57.56M
-3.37%-65.18M
31.08%-41.74M
-19.82%-94.69M
-91.01%-60.57M
-55.09%-63.05M
-285.46%-60.56M
-242.06%-79.03M
-122.31%-31.71M
-128.30%-40.66M
Net investment
58.49%40.07M
-20.73%35.86M
-55.31%26.03M
-18.05%18.90M
-67.10%25.28M
232.51%45.23M
187.48%58.24M
-90.48%23.07M
177.94%76.84M
52.95%-34.14M
-182.80%-66.58M
349.51%242.32M
-63.55%-98.59M
-272.53%-72.55M
22.28%80.40M
118.48%53.91M
86.92%-60.28M
414.72%42.05M
166.76%65.75M
-358.27%-291.65M
Net financing
--255.00K
-26.65%1.44M
100.00%0.00
80.91%1.47M
100.00%0.00
-70.11%1.96M
38.48%-50.20M
203.97%812.00K
96.78%-152.00K
-96.66%6.55M
-10063.61%-81.60M
-124.93%-781.00K
-1136.26%-4.71M
3658.18%195.99M
-38.14%819.00K
-98.95%3.13M
-84.20%455.00K
-99.40%5.21M
-98.95%1.32M
179.70%299.66M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its total revenue reached 160.00M, with a year-on-year change of 154.01M.

What are the current assets of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its current assets were 375.05M, with a year-on-year change of -24.34.

What are the total assets of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its total assets of Pacific Biosciences of California Inc were 784.08M, with a year-on-year change of -37.79.

What are the total liabilities of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its total liabilities of Pacific Biosciences of California Inc were 778.73M, with a year-on-year change of 3.30.

What is the total equity of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its total equity of Pacific Biosciences of California Inc was 5.35M, with a year-on-year change of -98.94.

What is the net operating income of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its net operating income of Pacific Biosciences of California Inc was -173.98M, with a year-on-year change of 35.29.

What is the net investment of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its net investment of Pacific Biosciences of California Inc was 115.45M, with a year-on-year change of -6.90.

What is the net financing of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its net financing of Pacific Biosciences of California Inc was 3.43M, with a year-on-year change of 107.97.

What is the Earnings Per Share (EPS) of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.82, with a year-on-year change of -61.36.

What is the net income of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its net income was -546.38M, with a year-on-year change of -76.34.

What is the net margin of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its net profit margin was -341.47, with a year-on-year change of -69.73.

What is the gross margin of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its gross margin was 27.95, with a year-on-year change of 112.30.

What is the debt-to-asset ratio of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its debt-to-asset ratio was 82.31, with a year-on-year change of 60.23.

What is the Return on Equity (ROE) of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its Return on Equity (ROE) was -213.45, with a year-on-year change of -316.05.

What is the Return on Assets (ROA) of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its Return on Assets (ROA) was -53.45, with a year-on-year change of -159.30.

What is the operating profit of Pacific Biosciences of California Inc?

According to Pacific Biosciences of California Inc's FY2025 earnings report, its operating profit was -173.98M, with a year-on-year change of 35.29.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy